Laser ablation therapy

An alternative treatment for medically resistant mesial temporal lobe epilepsy after age 50

Hena Waseem, Katie E. Osborn, Mike R. Schoenberg, Valerie Kelley, Ali Bozorg, Daniel Cabello, Selim R. Benbadis, Fernando Vale Diaz

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Selective anterior mesial temporal lobe (AMTL) resection is considered a safe and effective treatment for medically refractory mesial temporal lobe epilepsy (MTLE). However, as with any open surgical procedure, older patients (aged 50 +) face greater risks. Magnetic resonance-guided laser interstitial thermal therapy (MRgLITT) has shown recent potential as an alternative treatment for MTLE. As a less invasive procedure, MRgLITT could be particularly beneficial to older patients. To our knowledge, no study has evaluated the safety and efficacy of MRgLITT in this population.Seven consecutive patients (aged 50. +) undergoing MRgLITT for MTLE were followed prospectively to assess surgical time, complications, postoperative pain control, length of stay (LOS), operating room (OR) charges, total hospitalization charges, and seizure outcome. Five of these patients were assessed at the 1-year follow-up for seizure outcome. These data were compared with data taken from 7 consecutive patients (aged 50 +) undergoing AMTL resection.Both groups were of comparable age (mean: 60.7 (MRgLITT) vs. 53 (AMTL)). One AMTL resection patient had a complication of aseptic meningitis. One MRgLITT patient experienced an early postoperative seizure, and two MRgLITT patients had a partial visual field deficit. Seizure-freedom rates were comparable (80% (MRgLITT) and 100% (AMTL) (p. >. 0.05)) beyond 1. year postsurgery (mean follow-up: 1.0. years (MRgLITT) vs. 1.8. years (AMTL)). Mean LOS was shorter in the MRgLITT group (1.3. days vs. 2.6. days (p. <. 0.05)). Neuropsychological outcomes were comparable.Short-term follow-up suggests that MRgLITT is safe and provides outcomes comparable to AMTL resection in this population. It also decreases pain medication requirement and reduces LOS. Further studies are necessary to assess the long-term efficacy of the procedure.

Original languageEnglish (US)
Pages (from-to)152-157
Number of pages6
JournalEpilepsy and Behavior
Volume51
DOIs
StatePublished - Oct 1 2015
Externally publishedYes

Fingerprint

Temporal Lobe Epilepsy
Laser Therapy
Lasers
Magnetic Resonance Spectroscopy
Hot Temperature
Temporal Lobe
Seizures
Therapeutics
Length of Stay
Aseptic Meningitis
Operating Rooms
Operative Time
Postoperative Pain
Group Psychotherapy
Visual Fields
Population
Hospitalization

Keywords

  • Epilepsy surgery
  • Laser ablation
  • Magnetic resonance-guided laser interstitial thermal therapy
  • Medically resistant epilepsy
  • Temporal lobe epilepsy

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology
  • Behavioral Neuroscience

Cite this

Laser ablation therapy : An alternative treatment for medically resistant mesial temporal lobe epilepsy after age 50. / Waseem, Hena; Osborn, Katie E.; Schoenberg, Mike R.; Kelley, Valerie; Bozorg, Ali; Cabello, Daniel; Benbadis, Selim R.; Vale Diaz, Fernando.

In: Epilepsy and Behavior, Vol. 51, 01.10.2015, p. 152-157.

Research output: Contribution to journalArticle

Waseem, Hena ; Osborn, Katie E. ; Schoenberg, Mike R. ; Kelley, Valerie ; Bozorg, Ali ; Cabello, Daniel ; Benbadis, Selim R. ; Vale Diaz, Fernando. / Laser ablation therapy : An alternative treatment for medically resistant mesial temporal lobe epilepsy after age 50. In: Epilepsy and Behavior. 2015 ; Vol. 51. pp. 152-157.
@article{43f94f40a5c74970b6f97e271a5f9d2a,
title = "Laser ablation therapy: An alternative treatment for medically resistant mesial temporal lobe epilepsy after age 50",
abstract = "Selective anterior mesial temporal lobe (AMTL) resection is considered a safe and effective treatment for medically refractory mesial temporal lobe epilepsy (MTLE). However, as with any open surgical procedure, older patients (aged 50 +) face greater risks. Magnetic resonance-guided laser interstitial thermal therapy (MRgLITT) has shown recent potential as an alternative treatment for MTLE. As a less invasive procedure, MRgLITT could be particularly beneficial to older patients. To our knowledge, no study has evaluated the safety and efficacy of MRgLITT in this population.Seven consecutive patients (aged 50. +) undergoing MRgLITT for MTLE were followed prospectively to assess surgical time, complications, postoperative pain control, length of stay (LOS), operating room (OR) charges, total hospitalization charges, and seizure outcome. Five of these patients were assessed at the 1-year follow-up for seizure outcome. These data were compared with data taken from 7 consecutive patients (aged 50 +) undergoing AMTL resection.Both groups were of comparable age (mean: 60.7 (MRgLITT) vs. 53 (AMTL)). One AMTL resection patient had a complication of aseptic meningitis. One MRgLITT patient experienced an early postoperative seizure, and two MRgLITT patients had a partial visual field deficit. Seizure-freedom rates were comparable (80{\%} (MRgLITT) and 100{\%} (AMTL) (p. >. 0.05)) beyond 1. year postsurgery (mean follow-up: 1.0. years (MRgLITT) vs. 1.8. years (AMTL)). Mean LOS was shorter in the MRgLITT group (1.3. days vs. 2.6. days (p. <. 0.05)). Neuropsychological outcomes were comparable.Short-term follow-up suggests that MRgLITT is safe and provides outcomes comparable to AMTL resection in this population. It also decreases pain medication requirement and reduces LOS. Further studies are necessary to assess the long-term efficacy of the procedure.",
keywords = "Epilepsy surgery, Laser ablation, Magnetic resonance-guided laser interstitial thermal therapy, Medically resistant epilepsy, Temporal lobe epilepsy",
author = "Hena Waseem and Osborn, {Katie E.} and Schoenberg, {Mike R.} and Valerie Kelley and Ali Bozorg and Daniel Cabello and Benbadis, {Selim R.} and {Vale Diaz}, Fernando",
year = "2015",
month = "10",
day = "1",
doi = "10.1016/j.yebeh.2015.07.022",
language = "English (US)",
volume = "51",
pages = "152--157",
journal = "Epilepsy and Behavior",
issn = "1525-5050",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Laser ablation therapy

T2 - An alternative treatment for medically resistant mesial temporal lobe epilepsy after age 50

AU - Waseem, Hena

AU - Osborn, Katie E.

AU - Schoenberg, Mike R.

AU - Kelley, Valerie

AU - Bozorg, Ali

AU - Cabello, Daniel

AU - Benbadis, Selim R.

AU - Vale Diaz, Fernando

PY - 2015/10/1

Y1 - 2015/10/1

N2 - Selective anterior mesial temporal lobe (AMTL) resection is considered a safe and effective treatment for medically refractory mesial temporal lobe epilepsy (MTLE). However, as with any open surgical procedure, older patients (aged 50 +) face greater risks. Magnetic resonance-guided laser interstitial thermal therapy (MRgLITT) has shown recent potential as an alternative treatment for MTLE. As a less invasive procedure, MRgLITT could be particularly beneficial to older patients. To our knowledge, no study has evaluated the safety and efficacy of MRgLITT in this population.Seven consecutive patients (aged 50. +) undergoing MRgLITT for MTLE were followed prospectively to assess surgical time, complications, postoperative pain control, length of stay (LOS), operating room (OR) charges, total hospitalization charges, and seizure outcome. Five of these patients were assessed at the 1-year follow-up for seizure outcome. These data were compared with data taken from 7 consecutive patients (aged 50 +) undergoing AMTL resection.Both groups were of comparable age (mean: 60.7 (MRgLITT) vs. 53 (AMTL)). One AMTL resection patient had a complication of aseptic meningitis. One MRgLITT patient experienced an early postoperative seizure, and two MRgLITT patients had a partial visual field deficit. Seizure-freedom rates were comparable (80% (MRgLITT) and 100% (AMTL) (p. >. 0.05)) beyond 1. year postsurgery (mean follow-up: 1.0. years (MRgLITT) vs. 1.8. years (AMTL)). Mean LOS was shorter in the MRgLITT group (1.3. days vs. 2.6. days (p. <. 0.05)). Neuropsychological outcomes were comparable.Short-term follow-up suggests that MRgLITT is safe and provides outcomes comparable to AMTL resection in this population. It also decreases pain medication requirement and reduces LOS. Further studies are necessary to assess the long-term efficacy of the procedure.

AB - Selective anterior mesial temporal lobe (AMTL) resection is considered a safe and effective treatment for medically refractory mesial temporal lobe epilepsy (MTLE). However, as with any open surgical procedure, older patients (aged 50 +) face greater risks. Magnetic resonance-guided laser interstitial thermal therapy (MRgLITT) has shown recent potential as an alternative treatment for MTLE. As a less invasive procedure, MRgLITT could be particularly beneficial to older patients. To our knowledge, no study has evaluated the safety and efficacy of MRgLITT in this population.Seven consecutive patients (aged 50. +) undergoing MRgLITT for MTLE were followed prospectively to assess surgical time, complications, postoperative pain control, length of stay (LOS), operating room (OR) charges, total hospitalization charges, and seizure outcome. Five of these patients were assessed at the 1-year follow-up for seizure outcome. These data were compared with data taken from 7 consecutive patients (aged 50 +) undergoing AMTL resection.Both groups were of comparable age (mean: 60.7 (MRgLITT) vs. 53 (AMTL)). One AMTL resection patient had a complication of aseptic meningitis. One MRgLITT patient experienced an early postoperative seizure, and two MRgLITT patients had a partial visual field deficit. Seizure-freedom rates were comparable (80% (MRgLITT) and 100% (AMTL) (p. >. 0.05)) beyond 1. year postsurgery (mean follow-up: 1.0. years (MRgLITT) vs. 1.8. years (AMTL)). Mean LOS was shorter in the MRgLITT group (1.3. days vs. 2.6. days (p. <. 0.05)). Neuropsychological outcomes were comparable.Short-term follow-up suggests that MRgLITT is safe and provides outcomes comparable to AMTL resection in this population. It also decreases pain medication requirement and reduces LOS. Further studies are necessary to assess the long-term efficacy of the procedure.

KW - Epilepsy surgery

KW - Laser ablation

KW - Magnetic resonance-guided laser interstitial thermal therapy

KW - Medically resistant epilepsy

KW - Temporal lobe epilepsy

UR - http://www.scopus.com/inward/record.url?scp=84939483703&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939483703&partnerID=8YFLogxK

U2 - 10.1016/j.yebeh.2015.07.022

DO - 10.1016/j.yebeh.2015.07.022

M3 - Article

VL - 51

SP - 152

EP - 157

JO - Epilepsy and Behavior

JF - Epilepsy and Behavior

SN - 1525-5050

ER -